Signaling a major shift at the FDA, regulators put Amicus’ once-spurned drug on fast track

Signaling a major shift at the FDA, regulators put Amicus’ once-spurned drug on fast track

Submitted by admin on September 19, 2017 - 9:22am
Source: 
Endpoints
News Tags: 
FDA
Amicus Therapeutics
migalastat
Fabry disease
fast track
Headline: 
Signaling a major shift at the FDA, regulators put Amicus’ once-spurned drug on fast track

Do Not Allow Advertisers to Use My Personal information